Daniel Glenn Gibson

USPTO Granted Patents = 31 (Patent Applications = 14)

CIPO Patents = 7 (Patent Applications = 7)

EPO Patents = 14 (Patent Applications = 10)

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 368(Granted Patents)

Location History:

Mayfield Heights, OH (US) (2019)
Crofton, MD (US) (2010 - 2022)
Carlsbad, CA (US) (2017 - 2024)

Company Filing History:

14 out of 76

Synthetic Genomics, Inc.

Keene Building Products Co., Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371724 - Methods for in vitro joining and combinatorial assembly of nucleic acid molecules (2025-07-29),

2. 12234450 - Generation of synthetic genomes (2025-02-25),

3. 12065684 - Demand synthesis of polynucleotide sequences (2024-08-20),

4. 12018316 - Methods for assembling nucleic acids (2024-06-25),

5. 11884916 - Materials and methods for the synthesis of error-minimized nucleic acid molecules (2024-01-30),

6. 11746321 - Methods of cloning nucleic acids or producing proteins in a low endotoxin organism (2023-09-05),

7. 11618029 - Digital to biological converter (2023-04-04),

8. 11542529 - In vitro recombination method (2023-01-03),

9. 11408020 - Methods for in vitro joining and combinatorial assembly of nucleic acid molecules (2022-08-09),

10. 11085037 - Generation of synthetic genomes (2021-08-10),

11. 11060137 - Methods for assembling DNA molecules (2021-07-13),

12. 11027282 - Digital to biological converter (2021-06-08),

13. 10968496 - Recombinant Vibrio natriegens organisms having a modified outer membrane (2021-04-06),

14. 10704041 - Materials and methods for the synthesis of error-minimized nucleic acid molecules (2020-07-07),

15. 10626429 - Methods for in vitro joining and combinatorial assembly of nucleic acid molecules (2020-04-21),

Title: The Innovative Mind of Daniel Glenn Gibson

Introduction

Daniel Glenn Gibson, based in Crofton, Maryland, is a prolific inventor known for his significant contributions to the field of synthetic biology. With an impressive portfolio of 28 patents, Gibson's work focuses primarily on the methods of synthesizing DNA molecules and improving the efficiency of oligonucleotide assembly.

Latest Patents

Gibson's latest patents reflect his innovative thinking around polynucleotide synthesis. One notable invention is the method for demand synthesis of polynucleotide sequences. This invention provides a novel approach to synthesizing DNA molecules with predetermined sequences through the annealing of long and short oligonucleotides to an anchor strand. Another groundbreaking patent he holds involves methods for assembling nucleic acids, which facilitate the creation of DNA molecules with high sequence fidelity by using DNA ligases in conjunction with a carefully curated library of oligonucleotides.

Career Highlights

Throughout his career, Gibson has worked with esteemed organizations such as Synthetic Genomics, Inc. and Codex DNA, Inc. His work in these companies has further solidified his reputation as a key figure in advancing genetic engineering and synthetic biology, particularly in methods to efficiently create complex DNA sequences that have applications in various biotechnological fields.

Collaborations

Daniel Gibson has collaborated with prominent figures in science, including Hamilton O. Smith and J. Craig Venter. These partnerships have enabled him to leverage collective expertise in pushing the boundaries of genetic research and innovation.

Conclusion

Daniel Glenn Gibson continues to influence the field of synthetic biology through his inventive spirit and extensive patent portfolio. His contributions not only pave the way for future innovations in DNA synthesis but also highlight the importance of collaboration and ingenuity in scientific advancements.

This text is generated by artificial intelligence and may not be accurate.